Clinical Trial Update: A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating the safety of the combination of valsartan and amlodipine in hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: HYPERTENSION | Phase 3 | Status: COMPLETED